Associated Papers
An approach to predict and inhibit Amyloid Beta dimerization pattern in Alzheimer's disease.
Roy S et al.
Toxicology Reports, 2025
The AβA2V paradigm: From molecular insights to therapeutic strategies in Alzheimer's disease and primary tauopathies.
Diomede L et al.
Pharmacological Research, 2025
Mitochondrial CHCHD2: Disease-Associated Mutations, Physiological Functions, and Current Animal Models.
Kee TR et al.
Frontiers in Aging Neuroscience, 2021
Estrogens Inhibit Amyloid-β-Mediated Paired Helical Filament-Like Conformation of Tau Through Antioxidant Activity and miRNA 218 Regulation in hTau Mice.
Guglielmotto M et al.
Journal of Alzheimer's Disease : Jad, 2020
Identification of CHCHD2 mutations in patients with Alzheimer's disease, amyotrophic lateral sclerosis and frontotemporal dementia in China.
Liu X et al.
Molecular Medicine Reports, 2018
Mitochondrial CHCHD-Containing Proteins: Physiologic Functions and Link with Neurodegenerative Diseases.
Zhou ZD et al.
Molecular Neurobiology, 2017
The A2V mutation as a new tool for hindering Aβ aggregation: A neutron and x-ray diffraction study.
Cantu' L et al.
Scientific Reports, 2017
Alzheimer's Aβ peptides with disease-associated N-terminal modifications: influence of isomerisation, truncation and mutation on Cu2+ coordination.
Drew SC et al.
Plos One, 2010
Select a paper to view details